Montelukast Prescribing at WHITE HOUSE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
331
Total Quantity
6,370
NHS Cost
£320
vs National Avg
-51.7%
WHITE HOUSE SURGERY prescribed 331 items of Montelukast over the last 12 months at a cost of £320 to the NHS. This is 51.7% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
27
Jul 2026
24
Jul 2026
30
Jul 2026
28
Jul 2026
25
Jul 2026
29
Jul 2026
27
Jul 2026
29
Jul 2026
22
Jul 2026
28
Jul 2026
35
Jul 2026
27
Prescribing Details
| Total Items | 331 |
|---|---|
| Total Quantity | 6,370 |
| Total NHS Cost | £320 |
| Presentations | 3 different forms |
| vs National Average | -51.7% |
Montelukast Prescribing Comparison
| This practice | 331 items |
|---|---|
| National average per practice | 685 items |
| Difference | -51.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.